209 related articles for article (PubMed ID: 18055394)
61. [The metabolic syndrome. Part II: its mechanisms of development and its complications].
Pacholczyk M; Ferenc T; Kowalski J
Postepy Hig Med Dosw (Online); 2008 Oct; 62():543-58. PubMed ID: 18936730
[TBL] [Abstract][Full Text] [Related]
62. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
Ahmed I; Goldstein BJ
Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
[TBL] [Abstract][Full Text] [Related]
63. The progression of cardiovascular risk to cardiovascular disease.
Rosin BL
Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
[TBL] [Abstract][Full Text] [Related]
64. Association Among Obesity, Metabolic Health, and the Risk for Colorectal Cancer in the General Population in Korea Using the National Health Insurance Service-National Sample Cohort.
Shin CM; Han K; Lee DH; Choi YJ; Kim N; Park YS; Yoon H
Dis Colon Rectum; 2017 Nov; 60(11):1192-1200. PubMed ID: 28991084
[TBL] [Abstract][Full Text] [Related]
65. The link between abdominal obesity, metabolic syndrome and cardiovascular disease.
Ritchie SA; Connell JM
Nutr Metab Cardiovasc Dis; 2007 May; 17(4):319-26. PubMed ID: 17110092
[TBL] [Abstract][Full Text] [Related]
66. Adipose tissue, obesity and adipokines: role in cancer promotion.
Booth A; Magnuson A; Fouts J; Foster M
Horm Mol Biol Clin Investig; 2015 Jan; 21(1):57-74. PubMed ID: 25781552
[TBL] [Abstract][Full Text] [Related]
67. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
68. Obesity and metabolic syndrome: pathological effects on the gastrointestinal tract.
Feakins RM
Histopathology; 2016 Apr; 68(5):630-40. PubMed ID: 26599607
[TBL] [Abstract][Full Text] [Related]
69. Association between breast and colorectal cancers.
Stoll BA
Br J Surg; 1998 Nov; 85(11):1468-72. PubMed ID: 9823904
[TBL] [Abstract][Full Text] [Related]
70. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.
Dandona P; Aljada A; Chaudhuri A; Mohanty P; Garg R
Circulation; 2005 Mar; 111(11):1448-54. PubMed ID: 15781756
[No Abstract] [Full Text] [Related]
71. Association of Obesity-Related Metabolic Disruptions With Cancer Risk and Outcome.
Lohmann AE; Goodwin PJ; Chlebowski RT; Pan K; Stambolic V; Dowling RJ
J Clin Oncol; 2016 Dec; 34(35):4249-4255. PubMed ID: 27903146
[TBL] [Abstract][Full Text] [Related]
72. [Obesity and gastrointestinal cancer-related factor].
Kim DJ
Korean J Gastroenterol; 2012 Jan; 59(1):8-15. PubMed ID: 22289949
[TBL] [Abstract][Full Text] [Related]
73. Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.
Muc-Wierzgoń M; Nowakowska-Zajdel E; Dzięgielewska-Gęsiak S; Kokot T; Klakla K; Fatyga E; Grochowska-Niedworok E; Waniczek D; Wierzgoń J
World J Gastroenterol; 2014 Aug; 20(29):9759-74. PubMed ID: 25110413
[TBL] [Abstract][Full Text] [Related]
74. Obesity: the 'huge' problem in cardiovascular diseases.
Ashraf MJ; Baweja P
Mo Med; 2013; 110(6):499-504. PubMed ID: 24564002
[TBL] [Abstract][Full Text] [Related]
75. Chemoprevention of colorectal cancer by targeting obesity-related metabolic abnormalities.
Shirakami Y; Shimizu M; Kubota M; Araki H; Tanaka T; Moriwaki H; Seishima M
World J Gastroenterol; 2014 Jul; 20(27):8939-46. PubMed ID: 25083066
[TBL] [Abstract][Full Text] [Related]
76. Rethinking the Relationship between Insulin and Cancer.
Vigneri R; Sciacca L; Vigneri P
Trends Endocrinol Metab; 2020 Aug; 31(8):551-560. PubMed ID: 32600959
[TBL] [Abstract][Full Text] [Related]
77. Pseudodiabetes-not a contraindication for metabolic interventions.
Bravo-San Pedro JM; Sica V; Kroemer G
Cell Death Dis; 2019 Oct; 10(10):765. PubMed ID: 31601789
[TBL] [Abstract][Full Text] [Related]
78. Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis.
Shimizu M; Kubota M; Tanaka T; Moriwaki H
Int J Mol Sci; 2012; 13(1):579-595. PubMed ID: 22312273
[TBL] [Abstract][Full Text] [Related]
79. Pathophysiological Characteristics Linking Type 2 Diabetes Mellitus and Colorectal Neoplasia.
Grega T; Vojtechova G; Gregova M; Zavoral M; Suchanek S
Physiol Res; 2021 Aug; 70(4):509-522. PubMed ID: 34062073
[TBL] [Abstract][Full Text] [Related]
80. Obesity in people living with type 1 diabetes.
Van der Schueren B; Ellis D; Faradji RN; Al-Ozairi E; Rosen J; Mathieu C
Lancet Diabetes Endocrinol; 2021 Nov; 9(11):776-785. PubMed ID: 34600607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
